Ascend Laboratories Recalls

4 recalls found for Ascend Laboratories. Check if any of your products are affected.

Health & Personal Care
HIGH
FDA DRUG

ATORVASTATIN CALCIUM Tablets 10 mg Recall: 141,984 Bottles Nationwide (2025)

Ascend Laboratories, Parsippany, NJ is recalling 141,984 bottles of ATORVASTATIN CALCIUM Tablets USP, 10 mg, nationwide, manufactured by Alkem Laboratories, Ltd. in India. The issue is failed dissolution specifications, which could lead to improper dosing. Healthcare providers and patients should stop using the product and contact Ascend Laboratories for guidance.

ATORVASTATIN CALCIUM
Failed Dissolution
Read more
Health & Personal Care
HIGH
FDA DRUG

Ascend Laboratories Recalls Alkem Atorvastatin Calcium 20 mg Tablets for Dissolution Failures (3 NDC

Ascend Laboratories recalls Alkem Atorvastatin Calcium Tablets USP 20 mg for dissolution failures in 2025. Distributed by Ascend Laboratories, Parsippany, NJ, nationwide. The issue: dissolution specifications not met. Stop use immediately and follow recall instructions. Check your NDC numbers to identify affected lots.

Ascend Laboratories
Failed Dissolution
Read more
Health & Personal Care
HIGH
FDA DRUG

Ascend Laboratories Amlodipine and Olmesartan Medoxomil Recall for Low Dissolution 8,568 Bottles in

Ascend Laboratories recalls 8,568 bottles of Amlodipine and Olmesartan Medoxomil tablets due to failed dissolution specifications. The recall covers products manufactured by Alkem Laboratories in India and distributed nationwide in the USA. The defect involves low dissolution results. Stop use immediately and contact Ascend Laboratories for guidance.

Amlodipine and Olmesartan Medoxomil
Failed Dissolution
Read more

Brand Statistics

Total Recalls
4
Pages
1

Related Brands

ATORVASTATIN CALCIUMAlkem LaboratoriesAmlodipine and Olmesartan Medoxomil